---
title: "Microchip Tech Pref Shares MCHP 7.50 Perp 03/15/2028 | 8-K: FY2026 Q1 Revenue: USD 1.076 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252100599.md"
datetime: "2025-08-07T20:23:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252100599.md)
  - [en](https://longbridge.com/en/news/252100599.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252100599.md)
---

# Microchip Tech Pref Shares MCHP 7.50 Perp 03/15/2028 | 8-K: FY2026 Q1 Revenue: USD 1.076 B

Revenue: As of FY2026 Q1, the actual value is USD 1.076 B.

EPS: As of FY2026 Q1, the actual value is USD -0.09.

### Segment Revenue

Net sales for the first quarter of fiscal 2026 were $1.0755 billion, representing a sequential increase of 10.8% but a decline of 13.4% compared to the prior year’s first fiscal quarter.

### Operational Metrics

-   **GAAP Basis**: Gross profit was 53.6%, operating income was $32.1 million (3.0% of net sales), and net loss attributable to common stockholders was - $46.4 million, or - $0.09 per diluted share.
-   **Non-GAAP Basis**: Gross profit was 54.3%, operating income was $222.3 million (20.7% of net sales), and net income was $154.7 million, or $0.27 per diluted share.

### Cash Flow

GAAP cash flow from operations was $275.6 million, and free cash flow was $257.7 million for the quarter ended June 30, 2025.

### Unique Metrics

Inventory reduction of $124.4 million was achieved, with distribution inventory days reduced by 4 days to 29 days and inventory days on the balance sheet declining to 214 days.

### Outlook / Guidance

Microchip expects September quarter net sales of $1.130 billion plus or minus $20.0 million, representing approximately 5.1% sequential growth at the midpoint. The company is maintaining a disciplined approach given the evolving macro environment but believes it is well-positioned to deliver sustained growth and enhanced shareholder value throughout fiscal 2026.

### Related Stocks

- [MCHPP.US](https://longbridge.com/en/quote/MCHPP.US.md)

## Related News & Research

- [Why Iovance Biotherapeutics Stock Hit 52-Week High](https://longbridge.com/en/news/296522969.md)
- [Broadcom Stabilizes After Google's $120 Billion Marvell Shock](https://longbridge.com/en/news/296529317.md)
- [Nvidia Chip-Filled Data Centers Need More Power Than Any Utility Can Promise. Here's Who Actually Wins.](https://longbridge.com/en/news/296453760.md)
- [LIVE MARKETS-Rising AI-related debt issuance, widening tech CDS spreads: Is there a cliff up ahead?](https://longbridge.com/en/news/296519886.md)
- ['This Isn't the Time,' Says Investor About SpaceX Stock](https://longbridge.com/en/news/296503573.md)